Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA

Désirée van der Heijde, Maxime Dougados, Robert Landewé, Joachim Sieper, Walter P. Maksymowych, Martin Rudwaleit, Filip Van den Bosch, Jürgen Braun, Philip J. Mease, Alan J. Kivitz, Jessica Walsh, Owen Davies, Lars Bauer, Bengt Hoepken, Luke Peterson, Atul Deodhar

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint Dive into the research topics of 'Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA'. Together they form a unique fingerprint.

Medicine & Life Sciences